As of November 2024 Clarity Pharmaceuticals has 259.60M shares outstanding, a increase of 4.81% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 259.60M | 4.81% |
2022 | 247.70M | - |